Javascript must be enabled to continue!
Mortality Trends for Non–ST‐segment Elevation Myocardial Infarction (NSTEMI) in the United States from 1988 to 2004
View through CrossRef
AbstractBackground:Non–ST‐segment myocardial infarction (NSTEMI) is one of the major causes of hospital admissions. Mortality trend in patients with NSTEMI over the years has not been studied well. The goal of this study is to explore age‐adjusted long‐term mortality trends from NSTEMI in the United States using a very large database.Methods:We used the National Inpatient Sample (NIS) database, a component of the Health Care Cost and Utilization (HCUP) project, for this study. International Classification of Disease, Ninth Revision, Clinical Modification (ICD‐9‐CM) codes were used to identify NSTEMI cases in patients >40 years old. Age‐adjusted mortality rates for NSTEMI cases were calculated by multiplying the age‐specific mortality rates of NSTEMI by age‐specific weights.Results:A total of 1,400,234 patients above the age of 40 years were identified. The mean age of this cohort was 77.1±10.7 years, with a total of 179,361 deaths being reported over this 16‐year period. Among patients who died, 51.2% were men and 48.8% were women. The age‐adjusted mortality from NSTEMI declined from 1988 (727 per 100,000) to 2004 (305 per 100,000) until the middle of the decade when mortality from NSTEMI started leveling off. Total mortality decreased from 29.6% in 1988 to 11.3% in 2004.Conclusions:Our analysis showed a significant reduction in the age‐adjusted and total mortality for NSTEMI over the years studied. The cause of this trend is not known but most likely reflects advancement in the treatment of patients with acute coronary syndrome. © 2011 Wiley Periodicals, Inc.The authors have no funding, financial relationships, or conflicts of interest to disclose.
Title: Mortality Trends for Non–ST‐segment Elevation Myocardial Infarction (NSTEMI) in the United States from 1988 to 2004
Description:
AbstractBackground:Non–ST‐segment myocardial infarction (NSTEMI) is one of the major causes of hospital admissions.
Mortality trend in patients with NSTEMI over the years has not been studied well.
The goal of this study is to explore age‐adjusted long‐term mortality trends from NSTEMI in the United States using a very large database.
Methods:We used the National Inpatient Sample (NIS) database, a component of the Health Care Cost and Utilization (HCUP) project, for this study.
International Classification of Disease, Ninth Revision, Clinical Modification (ICD‐9‐CM) codes were used to identify NSTEMI cases in patients >40 years old.
Age‐adjusted mortality rates for NSTEMI cases were calculated by multiplying the age‐specific mortality rates of NSTEMI by age‐specific weights.
Results:A total of 1,400,234 patients above the age of 40 years were identified.
The mean age of this cohort was 77.
1±10.
7 years, with a total of 179,361 deaths being reported over this 16‐year period.
Among patients who died, 51.
2% were men and 48.
8% were women.
The age‐adjusted mortality from NSTEMI declined from 1988 (727 per 100,000) to 2004 (305 per 100,000) until the middle of the decade when mortality from NSTEMI started leveling off.
Total mortality decreased from 29.
6% in 1988 to 11.
3% in 2004.
Conclusions:Our analysis showed a significant reduction in the age‐adjusted and total mortality for NSTEMI over the years studied.
The cause of this trend is not known but most likely reflects advancement in the treatment of patients with acute coronary syndrome.
© 2011 Wiley Periodicals, Inc.
The authors have no funding, financial relationships, or conflicts of interest to disclose.
Related Results
FREQUENCY OF SIGNIFICANT LEFT MAIN CORONARY ARTERY INVOLVEMENT IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) VERSUS NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (NSTEMI)
FREQUENCY OF SIGNIFICANT LEFT MAIN CORONARY ARTERY INVOLVEMENT IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) VERSUS NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (NSTEMI)
Background: Left main coronary artery (LMCA) disease is a high-risk condition associated with significant morbidity and mortality in acute myocardial infarction (MI). While ST-segm...
FREQUENCY OF SIGNIFICANT LEFT MAIN CORONARY ARTERY INVOLVEMENT IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) VERSUS NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (NSTEMI)
FREQUENCY OF SIGNIFICANT LEFT MAIN CORONARY ARTERY INVOLVEMENT IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) VERSUS NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (NSTEMI)
Background: Left main coronary artery (LMCA) disease is a high-risk condition associated with significant morbidity and mortality in acute myocardial infarction (MI). While ST-segm...
FREQUENCY OF SIGNIFICANT LEFT MAIN CORONARY ARTERY INVOLVEMENT IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) VERSUS NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (NSTEMI)
FREQUENCY OF SIGNIFICANT LEFT MAIN CORONARY ARTERY INVOLVEMENT IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) VERSUS NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (NSTEMI)
Background: Left main coronary artery (LMCA) disease is a high-risk condition associated with significant morbidity and mortality in acute myocardial infarction (MI). While ST-segm...
A heveny szívinfarktus gyakoriságának és az általa okozott halálozás diurnalis és szezonális jellemzői Magyarországon
A heveny szívinfarktus gyakoriságának és az általa okozott halálozás diurnalis és szezonális jellemzői Magyarországon
Összefoglaló.
Bevezetés: A heveny szívinfarktus gyakoriságának és
halálozásának napi és szezonális ingadozása fontos epidemiológiai adat, ré...
Interplay Between Adiponectin, Resistin, Lipoprotein (A) and Prognosis in Middle to old age Female Cases with ST / Non ST Elevation Myocardial Infarction
Interplay Between Adiponectin, Resistin, Lipoprotein (A) and Prognosis in Middle to old age Female Cases with ST / Non ST Elevation Myocardial Infarction
Acute myocardial infarction (AMI) refers to ST-elevated myocardial infarction and non ST elevation myocardial infarction, is the known presentation of coronary artery disease. Stud...
THE CLINICAL VALUE OF MYOCARDIAL ENZYMES AND TROPONIN I COMBINED DETECTION FOR EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION
THE CLINICAL VALUE OF MYOCARDIAL ENZYMES AND TROPONIN I COMBINED DETECTION FOR EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION
Objectives
To investigate the clinical value of myocardial enzymes and troponin I combined detection for early diagnosis of acute myocardial infarction.
...
Abstract 14211: Positive Predictive Value of Troponin for NSTEMI Based on Chief Complaint
Abstract 14211: Positive Predictive Value of Troponin for NSTEMI Based on Chief Complaint
Introduction:
Serum troponin is a ubiquitous biomarker used to diagnose acute myocardial infarction (AMI). The positive predictive value (PPV) of high-sensitivity tropo...
Clinico-functional particularities of deceased patients with STEMI and NSTEMI 12 months after revascularization
Clinico-functional particularities of deceased patients with STEMI and NSTEMI 12 months after revascularization
Introduction: Acute myocardial infarction remains a leading cause of cardiovascular mortality worldwide [1 ]. However, ST-elevation MI (STEMI) and non-ST-elevation MI (NSTEMI) pati...

